The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PTEN loss as a potential biomarker in patients with castration resistant prostate cancer M0.
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
María Sánchez García
No Relationships to Disclose
 
Natalia Vidal
Speakers' Bureau - Astellas Pharma; AstraZeneca; Eisai; Janssen Oncology; MSD Oncology; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Pierre Fabre
 
Jesús Moreno
No Relationships to Disclose
 
David Hernández
No Relationships to Disclose
 
Jose Luis Senovilla
No Relationships to Disclose
 
Bernardo Herrera
No Relationships to Disclose
 
Alvaro Montesa
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Pfizer
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Asofarma; Astellas Pharma; Bayer; Johnson & Johnson
Research Funding - AB Science (Inst); Aragon Pharmaceuticals (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); BN ImmunoTherapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen-Cilag International NV (Inst); Karyopharm Therapeutics (Inst); Leurquin Mediolanum (Inst); Lilly (Inst); Medimmune (Inst); Millennium (Inst); Nanobiotix (Inst); Novartis (Inst); PFIZER (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi/Aventis (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AstraZéneca (Inst); BMS (Inst); Ipsen (Inst); Roche (Inst)
 
Jacques Planas
No Relationships to Disclose
 
Teresa Alonso Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck; Pfizer; Roche; Sanofi
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer; Sanofi
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi
Speakers' Bureau - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche Pharma AG
 
Sara Álvarez
No Relationships to Disclose
 
Francisco Javier Casas
No Relationships to Disclose
 
Mateo Paz Cabezas
No Relationships to Disclose
 
Ines de Torres
No Relationships to Disclose
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Daiichi Sankyo; Janssen; Janssen (Inst); MSD Oncology
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Bayer; Ipsen; Janssen; Roche